D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 83 Citations 24,248 327 World Ranking 587 National Ranking 291
Medicine D-index 87 Citations 26,226 350 World Ranking 8803 National Ranking 4676

Research.com Recognitions

Awards & Achievements

2015 - The Walter E. Stamm Mentor Award, Infectious Diseases Society of America

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Antibiotics
  • Disease

The scientist’s investigation covers issues in Internal medicine, Surgery, Transplantation, Immunology and Bacteremia. His biological study spans a wide range of topics, including Gastroenterology and Mycosis. The various areas that David R. Snydman examines in his Surgery study include Adverse effect, Clinical trial and Confidence interval.

He has researched Transplantation in several fields, including Congenital cytomegalovirus infection, Ganciclovir, Betaherpesvirinae and Human cytomegalovirus. His Immunology research integrates issues from Penicillin, Lactobacillus GG and Cefuroxime. His Bacteremia research incorporates elements of Enterococcus, Staphylococcus aureus, Drug resistance and Intensive care medicine.

His most cited work include:

  • Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection (880 citations)
  • Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial (815 citations)
  • The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance (696 citations)

What are the main themes of his work throughout his whole career to date?

David R. Snydman spends much of his time researching Internal medicine, Immunology, Microbiology, Transplantation and Surgery. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Bacteremia. His studies in Bacteremia integrate themes in fields like Prospective cohort study and Intensive care medicine.

His Microbiology research includes themes of Vancomycin and Bacteroides. His work deals with themes such as Immunosuppression, Betaherpesvirinae, Human cytomegalovirus and Ganciclovir, which intersect with Transplantation. David R. Snydman has included themes like Incidence and Confidence interval in his Surgery study.

He most often published in these fields:

  • Internal medicine (36.90%)
  • Immunology (31.02%)
  • Microbiology (22.46%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (36.90%)
  • Congenital cytomegalovirus infection (19.25%)
  • Clostridium difficile (8.56%)

In recent papers he was focusing on the following fields of study:

David R. Snydman mainly investigates Internal medicine, Congenital cytomegalovirus infection, Clostridium difficile, Microbiology and Vancomycin. Internal medicine and Gastroenterology are frequently intertwined in his study. His Congenital cytomegalovirus infection study introduces a deeper knowledge of Immunology.

His Immunology study incorporates themes from Fecal bacteriotherapy, Antimicrobial and Susceptibility testing. His work is dedicated to discovering how Microbiology, Agar are connected with Toxin, Bifidobacterium animalis and Gastrointestinal tract and other disciplines. His Vancomycin study combines topics from a wide range of disciplines, such as Antibiotics, Metronidazole and Bile acid.

Between 2016 and 2021, his most popular works were:

  • Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation (372 citations)
  • Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study. (33 citations)
  • Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009 (28 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Antibiotics
  • Disease

His primary scientific interests are in Internal medicine, Clostridium difficile, Microbiology, Vancomycin and Agar dilution. David R. Snydman interconnects Gastroenterology and Congenital cytomegalovirus infection in the investigation of issues within Internal medicine. The study incorporates disciplines such as Liver transplantation and Severity of illness in addition to Gastroenterology.

His studies deal with areas such as Transplantation and Bacteroides as well as Clostridium difficile. He specializes in Microbiology, namely Antibiotic resistance. His work carried out in the field of Agar dilution brings together such families of science as Toxin and Feces.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp.
JAMA (1994)

1513 Citations

Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection

Ioana Bica;Barbara McGovern;Barbara McGovern;Rakesh Dhar;David Stone;David Stone.
Clinical Infectious Diseases (2001)

1413 Citations

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

M. Hong Nguyen;James E. Peacock;Arthur J. Morris;David C. Tanner.
The American Journal of Medicine (1996)

985 Citations

Epidemiology of sepsis syndrome in 8 academic medical centers.

Kenneth E. Sands;David W. Bates;Paul N. Lanken;Paul S. Graman.
JAMA (1997)

931 Citations

Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients

Snydman Dr;Werner Bg;Heinze-Lacey B;Berardi Vp.
The New England Journal of Medicine (1987)

678 Citations

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens.
The New England Journal of Medicine (2017)

670 Citations

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

Mitchell P. Fink;David R. Snydman;Michael S. Niederman;Kenneth V. Leeper Jr..
Antimicrobial Agents and Chemotherapy (1994)

636 Citations

Risk and safety of probiotics.

Shira Doron;David R. Snydman.
Clinical Infectious Diseases (2015)

622 Citations

An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome

Victor L. Yu;Christine C. C. Chiou;Charles Feldman;Ake Ortqvist.
Clinical Infectious Diseases (2003)

543 Citations

Therapeutic Approaches in Patients With Candidemia: Evaluation in a Multicenter, Prospective, Observational Study

M. Hong Nguyen;James E. Peacock;David C. Tanner;Arthur J. Morris.
JAMA Internal Medicine (1995)

516 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David R. Snydman

Michael Boeckh

Michael Boeckh

Fred Hutchinson Cancer Research Center

Publications: 82

Raymund R. Razonable

Raymund R. Razonable

Mayo Clinic

Publications: 66

Issam I Raad

Issam I Raad

The University of Texas MD Anderson Cancer Center

Publications: 56

Nina Singh

Nina Singh

University of Pittsburgh

Publications: 53

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 51

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 47

Jordi Rello

Jordi Rello

Instituto de Salud Carlos III

Publications: 46

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 45

Michael J. Rybak

Michael J. Rybak

Wayne State University

Publications: 44

Po-Ren Hsueh

Po-Ren Hsueh

China Medical University

Publications: 44

Antoni Torres

Antoni Torres

University of Barcelona

Publications: 41

Robert H. Rubin

Robert H. Rubin

Brigham and Women's Hospital

Publications: 40

Jean Louis Vincent

Jean Louis Vincent

Université Libre de Bruxelles

Publications: 40

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 39

Paul D. Griffiths

Paul D. Griffiths

University College London

Publications: 39

Daniel J. Diekema

Daniel J. Diekema

University of Iowa Hospitals and Clinics

Publications: 38

Trending Scientists

Riccardo Poli

Riccardo Poli

University of Essex

Thomas Deselaers

Thomas Deselaers

Apple (United States)

Massimo Massa

Massimo Massa

INSEAD

Marek Behr

Marek Behr

RWTH Aachen University

Robert B. Noland

Robert B. Noland

Rutgers, The State University of New Jersey

Mark B. Shiflett

Mark B. Shiflett

University of Kansas

Dean A. Klein

Dean A. Klein

Micron (United States)

Hiromasa Ito

Hiromasa Ito

RIKEN Center for Advanced Photonics

Ralph Charles Mac Nally

Ralph Charles Mac Nally

University of Canberra

J. Allan Downie

J. Allan Downie

John Innes Centre

Elvira Richter

Elvira Richter

University of Erlangen-Nuremberg

Gregory Schraw

Gregory Schraw

University of Nevada, Las Vegas

Francis D. Moore

Francis D. Moore

Brigham and Women's Hospital

Lawrence F. Marshall

Lawrence F. Marshall

University of California, San Diego

Gerald McGwin

Gerald McGwin

University of Alabama at Birmingham

Alastair H. Leyland

Alastair H. Leyland

University of Glasgow

Something went wrong. Please try again later.